Simcere Pharmaceutical Group Announces 2025 AGM Agenda

An announcement from Simcere Pharmaceutical Group Limited ( (HK:2096) ) is now available.

Simcere Pharmaceutical Group Limited has announced its upcoming annual general meeting scheduled for June 13, 2025, in Shanghai. Key agenda items include the adoption of the 2024 financial statements, declaration of a final dividend, re-election of directors, and re-appointment of KPMG as auditors. The meeting will also consider granting the directors authority to issue additional shares, which could impact the company’s capital structure and shareholder value.

The most recent analyst rating on (HK:2096) stock is a Buy with a HK$8.20 price target. To see the full list of analyst forecasts on Simcere Pharmaceutical Group Limited stock, see the HK:2096 Stock Forecast page.

More about Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating within the pharmaceutical industry. It focuses on the development, production, and distribution of pharmaceutical products, with a market emphasis on innovative drugs and treatments.

Average Trading Volume: 8,127,981

Technical Sentiment Signal: Buy

Current Market Cap: HK$24.42B

For detailed information about 2096 stock, go to TipRanks’ Stock Analysis page.